| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.088 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |